Critical role of p42/44(MAPK) activation in anisomycin and hepatocyte growth factor-induced LDL receptor expression: activation of Raf-1/Mek-1/p42/44(MAPK) cascade alone is sufficient to induce LDL receptor expression.

The protein synthesis inhibitor anisomycin activates stress-related mitogen-activated protein kinases (MAPKs), namely, c-jun NH(2)-terminal kinase (p46/54(JNK)) and p38(MAPK) in mammalian cells. In this paper, we show that although exposure to anisomycin resulted in rapid and strong activation of p46/54(JNK) and p38(MAPK), with a delayed low level dual-phosphorylation of mitogen/extracellular protein kinase (p42/44(MAPK)), low density lipoprotein (LDL) receptor induction depends solely on the mild activation of p42/44(MAPK) signaling cascade in HepG2 cells. Unlike hepatocyte growth factor (HGF) which caused LDL receptor induction via rapid, strong, and Ras-dependent p42/44(MAPK) activation, anisomycin-induced p42/44(MAPK) activity and increased LDL receptor expression in a Ras-independent manner. Finally, we examined the role of the p42/44(MAPK) signaling cascade in LDL receptor induction by activating this kinase independently of anisomycin or HGF. By using estrogen-dependent human Raf-1 protein kinase in transient transfection assays, we show that the exclusive activation of the Raf-1/MEK-1/p42/44(MAPK) signaling cascade with antiestrogen ICI 182, 780 caused induction of LDL receptor expression to the same level as observed with either HGF or anisomycin. Consistent with the role of p42/44(MAPK), induction was strongly inhibited by pretreatment with the MEK-1/2 inhibitor PD98059. Our observation that anisomycin can use p42/44(MAPK) signaling cascade is a departure from established thinking, and the results presented shows that activation of the p42/44(MAPK) alone is sufficient to fully induce LDL receptor transcription.

[1]  C. Marshall,et al.  Specificity of receptor tyrosine kinase signaling: Transient versus sustained extracellular signal-regulated kinase activation , 1995, Cell.

[2]  M. J. Barratt,et al.  A mitogen‐ and anisomycin‐stimulated kinase phosphorylates HMG‐14 in its basic amino‐terminal domain in vivo and on isolated mononucleosomes. , 1994, The EMBO journal.

[3]  D. Stacey,et al.  Activation of JNK/SAPK pathway is not directly inhibitory for cell cycle progression in NIH3T3 cells. , 1996, Oncogene.

[4]  P. Sugden,et al.  Cellular Stresses Differentially Activate c-Jun N-terminal Protein Kinases and Extracellular Signal-regulated Protein Kinases in Cultured Ventricular Myocytes (*) , 1995, The Journal of Biological Chemistry.

[5]  J. Downey,et al.  Phosphorylation of tyrosine 182 of p38 mitogen-activated protein kinase correlates with the protection of preconditioning in the rabbit heart. , 1997, Journal of molecular and cellular cardiology.

[6]  M. Cobb,et al.  Mitogen-activated protein kinase pathways. , 1997, Current opinion in cell biology.

[7]  L. Schmidt,et al.  Negative regulation of serum-responsive enhancer elements , 1989, Nature.

[8]  L. Pirola,et al.  The Ras/Rac1/Cdc42/SEK/JNK/c-Jun cascade is a key pathway by which agonists stimulate DNA synthesis in primary cultures of rat hepatocytes. , 1998, Molecular biology of the cell.

[9]  M. McMahon,et al.  Mutations of critical amino acids affect the biological and biochemical properties of oncogenic A-Raf and Raf-1 , 1997, Oncogene.

[10]  Y. Oh,et al.  Activation of c-Jun N-terminal Kinase Antagonizes an Anti-apoptotic Action of Bcl-2* , 1997, The Journal of Biological Chemistry.

[11]  R. Treisman,et al.  Regulation of transcription by MAP kinase cascades. , 1996, Current opinion in cell biology.

[12]  A. Kumar,et al.  Phorbol ester-induced low density lipoprotein receptor gene expression in HepG2 cells involves protein kinase C-mediated p42/44 MAP kinase activation. , 1997, Journal of lipid research.

[13]  P. Lipsky,et al.  Non-sterol regulation of low density lipoprotein receptor gene expression in T cells. , 1994, Journal of lipid research.

[14]  E. Lees,et al.  Raf-induced proliferation or cell cycle arrest is determined by the level of Raf activity with arrest mediated by p21Cip1 , 1997, Molecular and cellular biology.

[15]  L. Mahadevan,et al.  Anisomycin Selectively Desensitizes Signalling Components Involved in Stress Kinase Activation and fos andjun Induction , 1998, Molecular and Cellular Biology.

[16]  G. Kapoor,et al.  One-way cross-talk between p38(MAPK) and p42/44(MAPK). Inhibition of p38(MAPK) induces low density lipoprotein receptor expression through activation of the p42/44(MAPK) cascade. , 1999, The Journal of biological chemistry.

[17]  K. Mehta,et al.  Identification of a Novel cis-Acting Element Participating in Maximal Induction of the Human Low Density Lipoprotein Receptor Gene Transcription in Response to Low Cellular Cholesterol Levels* , 1996, The Journal of Biological Chemistry.

[18]  T. Nakamura,et al.  Mitogen‐activated protein kinase activation in hepatocyte growth factor–stimulated rat hepatocytes: Involvement of protein tyrosine kinase and protein kinase C , 1996, Hepatology.

[19]  A. Levinson,et al.  Benzodiazepine peptidomimetics: potent inhibitors of Ras farnesylation in animal cells. , 1993, Science.

[20]  J. Swantek,et al.  Jun N-terminal kinase/stress-activated protein kinase (JNK/SAPK) is required for lipopolysaccharide stimulation of tumor necrosis factor alpha (TNF-alpha) translation: glucocorticoids inhibit TNF-alpha translation by blocking JNK/SAPK , 1997, Molecular and cellular biology.

[21]  K. Mehta,et al.  Differential Roles of Extracellular Signal-regulated Kinase-1/2 and p38MAPK in Interleukin-1β- and Tumor Necrosis Factor-α-induced Low Density Lipoprotein Receptor Expression in HepG2 Cells* , 1998, The Journal of Biological Chemistry.

[22]  E. Krebs,et al.  The MAPK signaling cascade , 1995, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[23]  G. Cooper,et al.  Differential regulation of Raf-1 and B-Raf and Ras-dependent activation of mitogen-activated protein kinase by cyclic AMP in PC12 cells , 1995, Molecular and cellular biology.

[24]  M. Greenberg,et al.  Effect of protein synthesis inhibitors on growth factor activation of c-fos, c-myc, and actin gene transcription , 1986, Molecular and cellular biology.

[25]  C. Malbon,et al.  jun N-terminal Kinase Mediates Activation of Skeletal Muscle Glycogen Synthase by Insulin in Vivo* , 1996, The Journal of Biological Chemistry.

[26]  H. Kawasaki,et al.  Ras-dependent and Ras-independent activation pathways for the stress-activated-protein-kinase cascade. , 1996, European journal of biochemistry.

[27]  L. Mahadevan,et al.  Parallel signal processing among mammalian MAPKs. , 1995, Trends in biochemical sciences.

[28]  A. Saltiel,et al.  Inhibition of MAP Kinase Kinase Blocks the Differentiation of PC-12 Cells Induced by Nerve Growth Factor(*) , 1995, The Journal of Biological Chemistry.

[29]  Jonathan A. Cooper,et al.  Mitogen and stress response pathways: MAP kinase cascades and phosphatase regulation in mammals and yeast. , 1995, Current opinion in cell biology.

[30]  Philip R. Cohen,et al.  SB 203580 is a specific inhibitor of a MAP kinase homologue which is stimulated by cellular stresses and interleukin‐1 , 1995, FEBS letters.

[31]  L. McKendrick,et al.  Involvement of Stress-activated Protein Kinase and p38/RK Mitogen-activated Protein Kinase Signaling Pathways in the Enhanced Phosphorylation of Initiation Factor 4E in NIH 3T3 Cells* , 1997, The Journal of Biological Chemistry.

[32]  T. Molski,et al.  Tyrosine phosphorylation and activation of a new mitogen-activated protein (MAP)-kinase cascade in human neutrophils stimulated with various agonists. , 1996, The Biochemical journal.

[33]  Jerry L. Adams,et al.  A protein kinase involved in the regulation of inflammatory cytokine biosynthesis , 1994, Nature.

[34]  R. Bravo Growth factor-responsive genes in fibroblasts. , 1990, Cell growth & differentiation : the molecular biology journal of the American Association for Cancer Research.

[35]  A. Minden,et al.  Regulation of a c-Jun Amino-terminal Kinase/Stress-activated Protein Kinase Cascade by a Sodium-dependent Signal Transduction Pathway* , 1997, The Journal of Biological Chemistry.